Max Healthcare Institute Limited (NSE:MAXHEALTH)

Max Healthcare Institute Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 28, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	974,149	935,815	1,066,148	797,357	428,177	336,359
Market Cap Growth	-10.80%	-12.22%	33.71%	86.22%	27.30%	69.00%
Enterprise Value	1,002,275	963,595	1,070,967	786,040	427,502	339,102
Last Close Price	1000.10	960.59	1093.74	816.09	438.32	345.46

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 28, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	66.86	64.88	99.10	75.39	38.80	55.59
PS Ratio	11.18	11.18	15.17	14.75	9.38	8.55
PB Ratio	9.06	8.71	11.37	9.48	5.78	5.35
P/TBV Ratio	20.55	19.75	31.87	28.22	18.27	28.70
P/FCF Ratio	654.71	628.95	216.05	237.51	45.14	179.70
P/OCF Ratio	59.64	57.30	74.14	71.09	33.34	45.42

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 28, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	11.50	11.51	15.24	14.54	9.37	8.61
EV/EBITDA Ratio	43.50	44.23	58.49	53.04	34.97	35.83
EV/EBIT Ratio	54.27	53.56	70.11	61.64	41.75	44.74
EV/FCF Ratio	673.62	647.62	217.02	234.14	45.07	181.16

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 28, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.32	0.32	0.32	0.15	0.09	0.14
Debt / EBITDA Ratio	1.51	1.55	1.60	0.86	0.55	0.94
Debt / FCF Ratio	-	23.38	6.10	3.87	0.73	4.88
Net Debt / Equity Ratio	0.26	0.26	0.25	0.04	-0.09	0.07
Net Debt / EBITDA Ratio	1.25	1.29	1.28	0.22	-0.56	0.46
Net Debt / FCF Ratio	-	18.90	4.76	0.95	-0.72	2.31
Asset Turnover	-	0.52	0.52	0.49	0.47	0.44
Inventory Turnover	-	28.55	28.50	26.31	25.17	30.36
Quick Ratio	-	0.80	0.78	1.19	1.67	1.18
Current Ratio	-	0.89	0.88	1.37	1.86	1.32
Return on Equity (ROE)	-	14.33%	12.10%	13.37%	16.12%	10.15%
Return on Assets (ROA)	-	6.93%	7.02%	7.21%	6.64%	5.34%
Return on Invested Capital (ROIC)	11.60%	12.25%	11.43%	12.79%	15.24%	9.68%
Return on Capital Employed (ROCE)	-	12.00%	11.40%	11.90%	11.30%	9.00%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 28, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	1.50%	1.54%	1.01%	1.33%	2.58%	1.80%
FCF Yield	0.15%	0.16%	0.46%	0.42%	2.21%	0.56%
Dividend Yield	0.20%	0.21%	0.14%	0.18%	0.23%	-
Payout Ratio	-	10.10%	13.53%	9.17%	-	-
Buyback Yield / Dilution	0.05%	0.00%	-0.20%	-0.39%	-0.24%	-12.30%
Total Shareholder Return	0.25%	0.21%	-0.07%	-0.20%	-0.01%	-12.30%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 29, 2026

Data Sources Report a data error